Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKinsey
Colorcon
Merck
AstraZeneca

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tositumomab

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Tositumomab?

Tositumomab is an investigational drug.

There have been 24 clinical trials for Tositumomab. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2005.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Lymphoma, Follicular. The leading clinical trial sponsors are GlaxoSmithKline, National Cancer Institute (NCI), and Southwest Oncology Group.

Recent Clinical Trials for Tositumomab
TitleSponsorPhase
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular LymphomaGlaxoSmithKlinePhase 2
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular LymphomaUniversity of Michigan Cancer CenterPhase 2
Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular LymphomaCephalonPhase 2

See all Tositumomab clinical trials

Clinical Trial Summary for Tositumomab

Top disease conditions for Tositumomab
Top clinical trial sponsors for Tositumomab

See all Tositumomab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
McKesson
Mallinckrodt
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.